Laura E Happe

Laura E Happe, Pharm.D., M.P.H.

Clinical Associate Professor; Director Of The POP Online M.S. Program

Department: Pharmaceutical Outcomes & Policy
Business Phone: (727) 488-2700
Business Email: lhappe@cop.ufl.edu

About Laura E Happe

Laura E. Happe, Pharm.D., M.P.H., is an editor, professor and author who specializes in using data to aid in decision making. Laura leads the online master’s degree program at the University of Florida College of Pharmacy, Department of Pharmaceutical Outcomes & Policy. The program was established in 2006 and graduates 50 students annually. Laura is also the Editor-in-Chief of the Journal of Managed Care and Specialty Pharmacy (JMCP), the official peer-reviewed journal of the Academy of Managed Care Pharmacy with a circulation of over 30,000 people. Laura also serves on the Board of Directors of Cardinal Innovations Healthcare, a managed Medicaid plan in North Carolina.

Previously, Laura was the Chief Pharmacy Officer of Humana, where she was responsible for advancing the clinical pharmacy acumen and integrating pharmacy into the company’s integrated care delivery model. During her time at Humana, she also enhanced the company’s research program, contributing to more than 70 peer-reviewed published manuscripts. She has more than 10 years of consulting experience with notable clients including GlaxoSmithKline, BMS, and Novartis.

Laura earned her Doctorate of Pharmacy degree from Creighton University and is a licensed pharmacist in both Florida and Arizona. She also holds a Master’s of Public Health degree with an emphasis in epidemiology from the University of South Florida and is fellowship trained in pharmacoeconomics and outcomes research. Laura’s first book, If You Give an Ox an Oxy, is an educational resource for parents to teach their adolescents about the hazards of opioid use.

Publications

2020
Application of a Graphical Depiction of Longitudinal Study Designs to Managed Care Pharmacy Research.
Journal of managed care & specialty pharmacy. 26(3):268-274 [DOI] 10.18553/jmcp.2020.26.3.268. [PMID] 32105168.
2020
Managed Care Pharmacy Research on Inappropriate Opioid Use Interventions.
Journal of managed care & specialty pharmacy. 26(10):1199-1202 [DOI] 10.18553/jmcp.2020.26.10.1199a. [PMID] 32996387.
2020
Editor’s note.
Journal of managed care & specialty pharmacy. 26(12) [DOI] 10.18553/jmcp.2020.26.12.1612. [PMID] 33252001.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(4) [DOI] 10.18553/jmcp.2020.26.4.341. [PMID] 32223595.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(6) [DOI] 10.18553/jmcp.2020.26.6.695. [PMID] 32463781.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(7) [DOI] 10.18553/jmcp.2020.26.7.816. [PMID] 32584685.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(1) [DOI] 10.18553/jmcp.2020.26.1.07. [PMID] 31880228.
2020
Top evidentiary gaps in managed care pharmacy: A research agenda
Journal Of Managed Care & Specialty Pharmacy. 26(4):375-381 [DOI] 10.18553/jmcp.2020.19372. [PMID] 32130069.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(8) [DOI] 10.18553/jmcp.2020.26.8.942. [PMID] 32715966.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(2) [DOI] 10.18553/jmcp.2020.26.2.85. [PMID] 32011967.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(3) [DOI] 10.18553/jmcp.2020.26.3.229. [PMID] 32105184.
2020
Editor’s note.
Journal of managed care & specialty pharmacy. 26(11) [DOI] 10.18553/jmcp.2020.26.11.1452. [PMID] 33119440.
2020
Distinguishing Predatory from Reputable Publishing Practices.
Journal of managed care & specialty pharmacy. 26(8):956-960 [DOI] 10.18553/jmcp.2020.26.8.956. [PMID] 32715959.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(9) [DOI] 10.18553/jmcp.2020.26.9.1067. [PMID] 32857649.
2020
Editor’s Note.
Journal of managed care & specialty pharmacy. 26(10) [DOI] 10.18553/jmcp.2020.26.10.1199. [PMID] 32996391.
2019
Announcing a New Article Series: Perspectives on Value.
Journal of managed care & specialty pharmacy. 25(1):8-9 [DOI] 10.18553/jmcp.2019.25.1.008. [PMID] 30589637.
2019
Graphical Depiction of Longitudinal Study Designs in Health Care Databases.
Annals of internal medicine. 170(6):398-406 [DOI] 10.7326/M18-3079. [PMID] 30856654.
2019
Incidence of non-melanoma skin cancer in the US population aged 65 years and older, 2014.
Journal of the American Academy of Dermatology. [DOI] 10.1016/j.jaad.2019.08.079. [PMID] 31499148.
2019
Primary Care Provider Encounter Cadence and HbA1c Control in Older Patients With Diabetes.
American journal of preventive medicine. 57(4):e95-e101 [DOI] 10.1016/j.amepre.2019.04.018. [PMID] 31542146.
2018
Alternative Payment Models in Medical Oncology: Assessing Quality-of-Care Outcomes Under Partial Capitation.
American health & drug benefits. 11(7):371-378 [PMID] 30647824.
View on: PubMed
2018
Outcomes at Bariatric Surgery Centers of Excellence and Non-Designated Centers: A Retrospective Cohort Study in a TRICARE Population.
The American surgeon. 84(3):410-415 [PMID] 29559057.
View on: PubMed
2018
Outcomes of a Digital Health Program With Human Coaching for Diabetes Risk Reduction in a Medicare Population.
Journal of aging and health. 30(5):692-710 [DOI] 10.1177/0898264316688791. [PMID] 28553807.
2017
Special Theme Issue: Oncology.
Journal of managed care & specialty pharmacy. 23(2) [DOI] 10.18553/jmcp.2017.23.2.122. [PMID] 28125368.
2017
Does a Free Office Visit Affect Primary Care-Seeking Behavior? A Study of New Exchange Health Plan Enrollees in Mississippi.
American health & drug benefits. 10(2):64-71 [PMID] 28626503.
View on: PubMed
2017
Family Physician Readiness for Value-Based Payments: Does Ownership Status Matter?
Population health management. 20(5):357-361 [DOI] 10.1089/pop.2016.0135. [PMID] 28099059.
2017
Leveraging Health-Related Quality of Life in Population Health Management: The Case for Healthy Days.
Population health management. 20(1):13-22 [DOI] 10.1089/pop.2015.0162. [PMID] 27031869.
2017
Missed Opportunities for Human Papillomavirus Vaccine Initiation in an Insured Adolescent Female Population.
Journal of the Pediatric Infectious Diseases Society. 6(4):360-365 [DOI] 10.1093/jpids/pix067. [PMID] 29036336.
2017
Presentation at computed tomography (CT) scan of the thorax and first year diagnostic and treatment utilization among patients diagnosed with lung cancer.
PloS one. 12(7) [DOI] 10.1371/journal.pone.0181319. [PMID] 28708876.
2016
Building Evidence for Pharmacist Interventions in Managed Care.
Journal of managed care & specialty pharmacy. 22(1) [DOI] 10.18553/jmcp.2016.22.1.8. [PMID] 27015046.
2016
Double-Digit Prescription Drug Spending Increase? Managed Care Pharmacists Saw It Coming.
Journal of managed care & specialty pharmacy. 22(2) [DOI] 10.18553/jmcp.2016.22.2.96. [PMID] 27015248.
2016
The physician-insurer dynamic must shift to successfully implement value-based payments.
Healthcare (Amsterdam, Netherlands). 4(4):282-284 [DOI] 10.1016/j.hjdsi.2016.06.004. [PMID] 27599395.
2016
Do Case Rates Affect Physicians’ Clinical Practice in Radiation Oncology?: An Observational Study.
PloS one. 11(2) [DOI] 10.1371/journal.pone.0149449. [PMID] 26870963.
2015
Comparative evaluation of patients newly initiating first-generation versus second-generation tyrosine kinase inhibitors for chronic myeloid leukemia and medication adherence, health services utilization, and healthcare costs.
Current medical research and opinion. 31(2):289-97 [DOI] 10.1185/03007995.2014.991440. [PMID] 25420131.
2015
Longitudinal evaluation of a colorectal cancer screenings measurement model
Journal of the National Comprehensive Cancer Network. 13
2015
Using sequence discovery to target outreach for diabetes medication adherence.
The American journal of managed care. 21(11):e601-8 [PMID] 26735293.
View on: PubMed
2014
A systematic literature review assessing the directional impact of managed care formulary restrictions on medication adherence, clinical outcomes, economic outcomes, and health care resource utilization.
Journal of managed care & specialty pharmacy. 20(7):677-84 [PMID] 24967521.
View on: PubMed
2014
Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis.
Journal of managed care & specialty pharmacy. 20(8):795-9 [PMID] 25062072.
View on: PubMed
2013
Choosing the best treatment for multiple sclerosis: comparative effectiveness, safety, and other factors involved in disease-modifying therapy choice.
The American journal of managed care. 19(17 Suppl):s332-42 [PMID] 24494634.
View on: PubMed
2013
Pharmacy Students for an Evolving Health Care Delivery System Through the Use of Grey Literature
American Journal of Pharmaceutical Education. 44(7):1-7
2013
Using grey literature to prepare pharmacy students for an evolving healthcare delivery system.
American journal of pharmaceutical education. 77(4) [DOI] 10.5688/ajpe77482. [PMID] 23716750.
2012
Approaches to the management of agents used for the treatment of multiple sclerosis: consensus statements from a panel of U.S. managed care pharmacists and physicians.
Journal of managed care pharmacy : JMCP. 18(1):54-62 [PMID] 22235955.
View on: PubMed
2009
Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.
Current medical research and opinion. 25(5):1081-7 [DOI] 10.1185/03007990902837117 . [PMID] 19298219.
2009
Impact of a pentavalent combination vaccine on immunization timeliness in a state Medicaid population.
The Pediatric infectious disease journal. 28(2):98-101 [DOI] 10.1097/INF.0b013e318187d047. [PMID] 19148039.
2009
Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants.
Current medical research and opinion. 25(2):413-20 [DOI] 10.1185/03007990802649133 . [PMID] 19192986.
2008
Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery.
The Annals of pharmacotherapy. 42(9):1216-21 [DOI] 10.1345/aph.1L135. [PMID] 18611992.
2008
Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries.
Journal of thrombosis and thrombolysis. 26(2):125-31 [PMID] 18034323.
View on: PubMed
2008
Decreased venous thromboembolism with injectable vs oral anticoagulation after discharge for major orthopedic surgery.
The Journal of arthroplasty. 23(6 Suppl 1):25-30 [DOI] 10.1016/j.arth.2008.05.017. [PMID] 18722300.
2008
Postdischarge oral versus injectable anticoagulation following major orthopedic surgery.
The Annals of pharmacotherapy. 42(9):1222-8 [DOI] 10.1345/aph.1L113. [PMID] 18664606.
2008
Venous thromboembolism clinically detected after hip fracture surgery with prophylaxis in a clinical practice setting.
American journal of orthopedics (Belle Mead, N.J.). 37(9):470-5 [PMID] 18982184.
View on: PubMed
2007
Combination vaccine use and vaccination quality in a managed care population.
The American journal of managed care. 13(9):506-12 [PMID] 17803364.
View on: PubMed
2007
Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 64(22):2349-55 [PMID] 17989444.
View on: PubMed
2007
Use of combination vaccines is associated with improved coverage rates.
The Pediatric infectious disease journal. 26(6):496-500 [PMID] 17529866.
View on: PubMed
2007
Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis.
Thrombosis research. 121(1):17-24 [PMID] 17449088.
View on: PubMed
2005
Pharmacoeconomic analysis of sequential treatment pathways in the treatment of onychomycosis
Managed Care Interface. 18(1):55-63 [PMID] 15682633.
View on: PubMed
2005
Relationship of total health care charges to selective serotonin reuptake inhibitor utilization patterns including the length of antidepressant therapy–results from a managed care administrative claims database
Journal of Managed Care Pharmacy. 11(2):145-150 [DOI] 10.18553/jmcp.2005.11.2.145. [PMID] 15766321.
2004
Pharmacoeconomic evaluation of antidepressant therapies
Managed Care Interface. 13(6):34-41 [PMID] 15293769.
View on: PubMed

Teaching Profile

Courses Taught
2020-2021
PHA6910 Supervised Research
2019-2021
PHA6935 Selected Topics in Pharmacy
2020-2021
PHA6938 Research Seminar
2019-2020
PHA6276 Pharmacy Benefit Design & Management

Contact Details

Phones:
Business:
(727) 488-2700
Emails:
Business:
lhappe@cop.ufl.edu